Guidelines for submitting a dermatological product to the ACBS
Information and advice on submitting a dermatological product to the Advisory Committee for Borderline Substances (ACBS).
Documents
Details
This set of documents contains supporting information for use in submitting a dermatological product for consideration by the Advisory Committee for Borderline Substances (ACBS).
This includes:
- the mechanism for ensuring patient safety
- products that will not be considered
- clinical trial information be applied for type 1 products
The documents can be used when filling out the dermatological products application form.